ConductScience.org, home
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
API referenceFor AI assistants

Trial · NCT04498169

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Modified Intent-to-Treat PopulationSTARTEDOnce Daily Netarsudil Ophthalmic Solution20
Modified Intent-to-Treat PopulationSTARTEDTwice Daily Netarsudil Ophthalmic Solution20
Modified Intent-to-Treat PopulationCOMPLETEDOnce Daily Netarsudil Ophthalmic Solution19
Modified Intent-to-Treat PopulationCOMPLETEDTwice Daily Netarsudil Ophthalmic Solution19
Modified Intent-to-Treat PopulationNOT COMPLETEDOnce Daily Netarsudil Ophthalmic Solution1
Modified Intent-to-Treat PopulationNOT COMPLETEDTwice Daily Netarsudil Ophthalmic Solution1
Safety PopulationSTARTEDOnce Daily Netarsudil Ophthalmic Solution20
Safety PopulationSTARTEDTwice Daily Netarsudil Ophthalmic Solution20
Safety PopulationCOMPLETEDOnce Daily Netarsudil Ophthalmic Solution19
Safety PopulationCOMPLETEDTwice Daily Netarsudil Ophthalmic Solution19
Safety PopulationNOT COMPLETEDOnce Daily Netarsudil Ophthalmic Solution1
Safety PopulationNOT COMPLETEDTwice Daily Netarsudil Ophthalmic Solution1
Per-Protocol PopulationSTARTEDOnce Daily Netarsudil Ophthalmic Solution18
Per-Protocol PopulationSTARTEDTwice Daily Netarsudil Ophthalmic Solution16
Per-Protocol PopulationCOMPLETEDOnce Daily Netarsudil Ophthalmic Solution18
Per-Protocol PopulationCOMPLETEDTwice Daily Netarsudil Ophthalmic Solution15
Per-Protocol PopulationNOT COMPLETEDOnce Daily Netarsudil Ophthalmic Solution0
Per-Protocol PopulationNOT COMPLETEDTwice Daily Netarsudil Ophthalmic Solution1
Study CompletionSTARTEDOnce Daily Netarsudil Ophthalmic Solution20
Study CompletionSTARTEDTwice Daily Netarsudil Ophthalmic Solution20

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04498169/flow

API referenceFor AI assistants